U.S. markets open in 9 hours 13 minutes
  • S&P Futures

    4,388.00
    -33.75 (-0.76%)
     
  • Dow Futures

    34,137.00
    -325.00 (-0.94%)
     
  • Nasdaq Futures

    15,236.00
    -90.00 (-0.59%)
     
  • Russell 2000 Futures

    2,205.20
    -23.10 (-1.04%)
     
  • Crude Oil

    71.41
    -0.56 (-0.78%)
     
  • Gold

    1,745.50
    -5.90 (-0.34%)
     
  • Silver

    22.08
    -0.26 (-1.15%)
     
  • EUR/USD

    1.1715
    -0.0016 (-0.14%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.81
    +2.12 (+11.34%)
     
  • GBP/USD

    1.3709
    -0.0028 (-0.20%)
     
  • USD/JPY

    109.9200
    +0.0250 (+0.02%)
     
  • BTC-USD

    45,456.62
    -2,527.75 (-5.27%)
     
  • CMC Crypto 200

    1,133.56
    -91.97 (-7.50%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

Option Care Health (NASDAQ:OPCH) Shareholders Will Want The ROCE Trajectory To Continue

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Speaking of which, we noticed some great changes in Option Care Health's (NASDAQ:OPCH) returns on capital, so let's have a look.

Understanding Return On Capital Employed (ROCE)

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on Option Care Health is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.059 = US$131m ÷ (US$2.6b - US$420m) (Based on the trailing twelve months to March 2021).

Thus, Option Care Health has an ROCE of 5.9%. In absolute terms, that's a low return and it also under-performs the Healthcare industry average of 11%.

See our latest analysis for Option Care Health

roce
roce

Above you can see how the current ROCE for Option Care Health compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.

What Does the ROCE Trend For Option Care Health Tell Us?

We're glad to see that ROCE is heading in the right direction, even if it is still low at the moment. The numbers show that in the last three years, the returns generated on capital employed have grown considerably to 5.9%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 85%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.

The Key Takeaway

To sum it up, Option Care Health has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And with a respectable 14% awarded to those who held the stock over the last year, you could argue that these developments are starting to get the attention they deserve. Therefore, we think it would be worth your time to check if these trends are going to continue.

If you want to know some of the risks facing Option Care Health we've found 2 warning signs (1 is a bit concerning!) that you should be aware of before investing here.

While Option Care Health isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.